Discover how automation, AI, and organoid technologies are improving drug discovery through scalable workflows.
The invisible architect: How Keval Barvaliya is quietly saving Fortune 500 Companies from themselves
As most technologists seek the limelight of AI and blockchain, Keval Barvaliya has spent his career doing something far more ...
Entries will be assessed on criteria including AI integration, spatial intelligence, feasibility, sustainability, inclusivity, human-centred design and the ability to translate data into practical des ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results